BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38158698)

  • 1. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
    MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
    FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
    Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
    J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
    Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
    J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.
    Kraft JR; Vance RE; Pohl J; Martin AM; Raulet DH; Jensen PE
    J Exp Med; 2000 Sep; 192(5):613-24. PubMed ID: 10974028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of functional Cd94 polymorphism in a free-living house mouse population.
    Knutsen LE; Dissen E; Saether PC; Bjørnsen EG; Piálek J; Storset AK; Boysen P
    Immunogenetics; 2019 Apr; 71(4):321-333. PubMed ID: 30535636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
    Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
    J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
    O'Callaghan CA
    Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.
    Vance RE; Jamieson AM; Raulet DH
    J Exp Med; 1999 Dec; 190(12):1801-12. PubMed ID: 10601355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
    Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
    Pietra G; Romagnani C; Moretta L; Mingari MC
    Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Domain TCR-like Antibody Selective for the Qa-1
    Ghaffari S; Upchurch-Ange K; Gimlin S; Tripathi T; Sluijter M; Middelburg J; van Hall T; Weidanz J
    J Immunol; 2022 May; 208(9):2246-2255. PubMed ID: 35418467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
    Vance RE; Kraft JR; Altman JD; Jensen PE; Raulet DH
    J Exp Med; 1998 Nov; 188(10):1841-8. PubMed ID: 9815261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for NKG2A/CD94 recognition of HLA-E.
    Kaiser BK; Pizarro JC; Kerns J; Strong RK
    Proc Natl Acad Sci U S A; 2008 May; 105(18):6696-701. PubMed ID: 18448674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.
    Sullivan LC; Clements CS; Beddoe T; Johnson D; Hoare HL; Lin J; Huyton T; Hopkins EJ; Reid HH; Wilce MC; Kabat J; Borrego F; Coligan JE; Rossjohn J; Brooks AG
    Immunity; 2007 Dec; 27(6):900-11. PubMed ID: 18083576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.